In the competitive world of biotechnology, having a strong online presence is crucial for success. The right SEO agency can ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

The suit centers on mid-stage clinical trials that injured eight patients at five trial sites in the early 2020s. A Peninsula biotech company is suing to force its insurer to cover $3 million in ...

Jan. 23, 2025 — Researchers have uncovered which genes on the Y chromosome regulate the development of sperm and impact fertility in male mice. This research could help us understand why some ...

Aspiring participants of the GATE 2025 Biotechnology (BT) exam must go through the syllabus of Biotechnology (BT). The ...

All of this means it's unlikely Viking will upset the market's current leaders. That said, this newer biotech player could eventually carve out a spot if all continues to go well in clinical studies.

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes ...

While 2024 was a “challenging” year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months. On November 28 ...

Dylan Lewis: We're talking three stocks down bad. Motley Fool Money starts down. I'm Dylan Lewis, I'm joined over the ...

(Tune Photos) Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest funding rounds for a Seattle-area startup in recent years.